High levels of pro-inflammatory cytokines, such as IL-6 and TNF-α, are shared by psoriasis and depression, leading to alterations in serotonin, norepinephrine, and dopamine metabolism in the limbic system and basal ganglia, contributing to depressive symptoms [13]. This evidence concerns the gene TNF and depressive symptom measurement.